A series of azaphilones produced by Penicillium sclerotiorum (Xenova culture collection number XI 1 853) active in assays for the detection of antagonists of the endothelin-A (ETA) and endothelin-B (ETB) receptors has been identified. The series includes two novel sclerotiorin analogues, ($S,%a-R)-7-deacetyl-l ,O 8,8,8a-tetrahydro-7-à¬>/?/-sclerotiorin, 1, and its 5-dechloro analogue, 2. It also includes 5-chloroisorotiorin, 6, previously unreported as a natural product, in addition to the major product of these fermentations, (+)-sclerotiorin, 5. Data for the inhibition of endothelin-1 (ET-1) and endothelin-3 (ET-3) binding in the ETAand ETBreceptor assays respectively are reported for this series. Compounds1 and 2 were more selective for the rabbit ETAreceptor than for the rat ETB receptor. The IC50 values for 1 and 2 were 9 and 28/*m respectively in an assay based on binding of ET-1 to rabbit ETAreceptors. In an assay based on the binding of ET-3 to the rat ETBreceptor The endothelins (which exist as three isoforms: ET-1, ET-2 and ET-3) are a family of potent vasoconstricting peptides with a variety of biological activities including bronchoconstriction, positive inotropic and chronotropic effects, mitogenesis and potent renal effects. Endothelins are implicated in several human disease states including hypertension, congestive heart failure, renal failure, pulmonary hypertension, ischemia and cerebral vasospasm1 "40. Recent results obtained with mice deficient in endothelin-1 suggest that it is essential for normal mouse development and may also play a physiological role in cardiovascular homeostasis5). non-selective receptor, recognising the ET isopeptides with equal affinity, was originally identified as the non-vascular smooth muscle receptor. This receptor is localised on endothelial cells in certain tissues and has been associated with vasodilatory activity, perhaps through the release of the endothelin-derived relaxing factor (EDRF). It has been reported, however, that the ETBreceptor is also localised on vascular smooth muscle and mediates a vasoconstrictor response in certain tissues/species. The use of endothelin receptor antagonists is furthering the understanding of the pathophysiological role of the endothelins17~22).
endothelin-3 (ET-3) binding in the ETAand ETBreceptor assays respectively are reported for this series. Compounds1 and 2 were more selective for the rabbit ETAreceptor than for the rat ETB receptor. The IC50 values for 1 and 2 were 9 and 28/*m respectively in an assay based on binding of ET-1 to rabbit ETAreceptors. In an assay based on the binding of ET-3 to the rat ETBreceptor The endothelins (which exist as three isoforms: ET-1, ET-2 and ET-3) are a family of potent vasoconstricting peptides with a variety of biological activities including bronchoconstriction, positive inotropic and chronotropic effects, mitogenesis and potent renal effects. Endothelins are implicated in several human disease states including hypertension, congestive heart failure, renal failure, pulmonary hypertension, ischemia and cerebral vasospasm1 "40. Recent results obtained with mice deficient in endothelin-1 suggest that it is essential for normal mouse development and may also play a physiological role in cardiovascular homeostasis5).
Two subtypes of endothelin receptors, classified as ETAand ETBreceptors, have been cloned and characterised in mammalian systems6~9). Both receptor subtypes are rhodopsin-like in structure and are coupled to G-proteins under study12~16). The ETAreceptor mediates vasoconstriction and mitogenic responses and is widely localised in vascular smooth muscle in most tissues. The ETB, or non-selective receptor, recognising the ET isopeptides with equal affinity, was originally identified as the non-vascular smooth muscle receptor. This receptor is localised on endothelial cells in certain tissues and has been associated with vasodilatory activity, perhaps through the release of the endothelin-derived relaxing factor (EDRF). It has been reported, however, that the ETBreceptor is also localised on vascular smooth muscle and mediates a vasoconstrictor response in certain tissues/species. The use of endothelin receptor antagonists is furthering the understanding of the pathophysiological role of the endothelins17~22).
The endothelin antagonists discovered to date from microbial sources are predominantly actinomycete metabolites. These include the ETA Wehave developed a high-throughput screen for ETA receptor binding for use in conducting a microbial screening programmeconcentrated on fungal samples. This programmehas been successful in identifying several newseries of endothelin receptor antagonists, the first of which, a family of azaphilones produced by a naturally occuring micro fungus, are reported herein. The structures of the azaphilones, two of which (1 and 2) are novel fungal metabolites, are shown in Figure 1 .
Materials and Methods Preparation of Membranes for ETAReceptor Binding
Assay ETAsubtype receptors were prepared from cultured rabbit renal artery vascular smooth muscle (RRA-VSM) cell membranes. The culture medium consisted of DME/Ham'sF12 (Dulbeccos Modifed Eagle medium) (1 : 1) and 10% FBS (fetal bovine serum). The cells were sub-cultured at con fluency by washing with CMF-PBS (calcium and magnesium free phosphate buffered saline) and incubating for 5 minutes with CMF-PBScontaining 0.05% trypsin and 0.02% EDTA (Ethylenediaminetetraacetic acid) at 37°C. The cells were then split at a dilution of 1 in 10. Cells were grown in 150mmdishes. 
Preparation of Membranesfor ETBReceptor Binding
Assay ETBsubtype receptors were prepared from rat brain cerebellum. Dura and blood vessels were removed from rat brain cerebella and the tissue stored at -80°C until required. Whenrequired the tissue was re-suspended in 2.5 ml ice-cold homogenization buffer (250 mMsucrose, 20mMTris, 2mMEDTA, pH 7.4) and homogenized in a pre-cooled motor-driven Teflon pestle using slow then high speed. The homogenate was centrifuged at 30,000 x g for 20minutes at 4°C. The supernatant was discarded and the pellet re-suspended in 2 ml ice-cold buffer (0.9% NaCl, 20mM Tris, 5 mMEDTA, pH 7.4) per cerebellum. Membrane preparations were aliquoted and stored at -80°C until required.
ETBReceptor Binding Assay Fermentation of Organism A suspension from a mature slant culture, grownon MEA(2% malt extract, 1.5% agar) was transferred into a 250-ml Erlenmeyer flask containing 40 ml seed medium. The seed mediumconsisted of glycerol, D-glucose, malt extract, soybean peptone, NaCl and CaCO3, adjusted to pH 6 with hydrochloric acid before sterilisation. The flask was shaken at 240rpm and 25°C for 3days and transferred into a 2-liter Erlenmeyer flask containing 250ml seed medium. This flask was shaken for another 3 days under the sameconditions. The contents of the flask were transferred to a 14-liter fermenter containing 1 1 liters of the following medium: beet molasses, casein, phytic acid, CaCO3 and antifoam A (Sigma), adjusted to pH 6 with hydrochloric acid before sterilisation.
The vessel was agitated for 150hours at 450 rpm and aerated at 0.5 vvm. The temperature was controlled at 25°C.
Dissolved oxygen tension (DOT) and pH were monitored via Ingold probes and dry cell weight (DCW) was determined by conventional methods. Production of compounds of interest was monitored by extracting biomass from 10ml aliquots of culture with methanol (3.x 10 ml). The extracts were analysed by reverse phase HPLCon a Waters Novapak C-18 column with photodiode array detection, eluting with a water -acetonitrile gradient (0-> 100% over 13 minutes). Biological Activity The concentration of the isolated compounds 1~3, 5~7 which resulted in a 50% inhibition of the endothelin binding (IC50) to the relevant receptor membrane preparation was determined in the assay described.
Results
Taxonomy of Fungus XI 1853 This fungus was identified as a strain of Penicillium sclerotiorum on the basis of its morphological characteristics following inoculation at the centre of Petri dishes containing two different media, Czapek Dox (Unipath Ltd) agar (CZ) and 2%malt extract (Difco Laboratories) agar (2% MEA), using conidia transferred on a sterile agar-coated needle. Over a period of ten days, the mycelial diameter extension rate at 25°C was within the range .0 x 1.9/mi, with smooth to finely roughened walls. These morphological characteristics are in accordance with the variation described for Penicillium sclerotiorum van Beyma, although the values for mycelial extension are lower than stated as typical for the species34). Fermentation
The changes in pH, DOT, DCW,and concentration of 1 that occured during the fermentation are shown in NMRspectra and optical rotation of 6 were identical to those reported for ( + )-5-chloroisorotiorin obtained by a synthetic route37). 5-chloroisorotiorin has not previously been reported as a natural product. The XHand 13C NMRassignments for 5 and 6 are given in Table 1 .
Compound 3 was found to be identical with the recently reported monoamine oxidase inhibitor (8i?)-7-deacetyl-0 8,8-dihydro-7-epz-sclerotiorin from Talaromyces Iuteus38>39). Its UV, mass, XH and 13C NMR spectra were as reported. When3 was purified from previous fermentations of P. sclerotiorum XI 1853 it was occasionally contaminated with small quantities of 4, its 1 1-(Z) isomer, which was also reported as a Tataromyces luteus metabolite3 8).
Compound7 was identified as ochrephilone, previously reported as a metabolite of Penicillium multicolor^, by its UV, IR, mass, XHand 13C NMRspectra. Spectra were measured at 25°C. TMSwas used as an internal reference (S 0.00).
Chemical shifts are expressed in ppm and coupling constants in Hz, * These assignments are interchangeable. Structure Elucidation of 1 and 2 The physico-chemical properties of 1 and 2 are shown in Table 2 . The XH and 13C NMRspectra of1 were very similar to those of sclerotiorin, the main differences being the absence of the olefinic proton and carbon signals for C-l, the absence of signals for an acetyl group at C-7 and the presence of four new, highly coupled proton signals at 8 4.86, 3.82, 3.47 and 3.14. The HMQCNMR spectrum showed that the proton signals at 8 4.86 and 3.47 were due to a non-equivalent pair of methylene protons attached to a carbon with a shift of 8 68.8. The proton signals at 8 3.47 and 3.14 were likewise due to methine protons attached to carbons with shifts of 8 73.6 and 37.7 respectively. Consideration of these chemical shift data and inspection of the COSY-45NMRspectrum suggested the partial structure shown in Figure 3 .
These NMR data and the molecular formula of C19H25O4C1 indicated by HR-EI-MS suggested that 1 was a reduced 7-deacetylsclerotiorin.
Comparison of the NMRdata for 1 and 5 required 1 to be 7-deacetyll ,0 8,8,8a-tetrahydrosclerotiorin. This was confirmed by correlations observed in the HMBC NMRspectrum of 1, these correlations are shown in Figure 4 .
The scalar coupling constants for the proton spin system comprising the methylene protons at C-l and the methine protons at C-8 and C-8a are almost identical to those reported for the very similar system present in the recently reported azaphilone, falconensin A41). Cross peaks observed in the NOESY NMRspectrum of 1 suggested that these four protons have the same spatial arrangement as their counterparts in falconensin A. In contrast to the NOEresults observed for falconensin A, however, there was no cross peak observed for the protons of the methyl group attached to C-7 and the proton at C-8a; the only cross peak observed for these methyl protons was with the proton at C-8. These Identical NOE's were observed for 2, with an additional interaction for the proton at C-5. observations are best accomodated by the relative stereochemistry indicated for 1, the configuration at C-7 being the opposite of that reported for falconensin A. The NOEenhancements observed in the NOESYNMR spectrum of 1 are shown in Figure 5 . The *H and 13C NMRspectra of 2 were very similar to those of 1, the main difference being the presence of an extra proton singlet at d 5.72. The molecular formula of C19H26O4 suggested by HR-EI-MS indicated the replacement of the chlorine in the structure of 1 by a hydrogen to generate the 5-dechloro-analogue of 1. This was confirmed by correlations observed in the HMBC NMRspectrum of 2. The 1H and 13C NMRassignments for 1 and 2 are given in Table 1 .
Biological Properties
Endothelin Receptor Assays The IC50 values of compounds 1~3 and 5~7 and the azaphilone-related compound citrinin 8, for inhibition of endothelin binding in the rabbit ETAand rat ETBreceptor assays are shown in Table 3 . The IC50 curve for 1 in the rabbit ETAreceptor assay is shown in Figure 6 . The IC50 curve for 1 in the rat ETB receptor assay is shown in Figure 7 . The IC50 values for compounds 1~3 and 5~7 in the humanETAand ETBreceptor assays are shown in Table 3 .
Citrinin 8 was not active in either the rabbit ETAand rat ETB receptor assays at any of the concentrations tested. The known microbial ETAantagonists asterric acid and BE-18257Bwere also tested in the rabbit ETA assay and their IC50 values, also shown in Table 3, agree with those reported23'26*.
Arachidonic Acid Release Assay (AARA) Compounds 1, 3, 5, 6 and 7 were active at 30jUM in the AARAassay although the IC50 values determined were in excess of 30fiM. This data is shown in Table 3 . The most active was compound 3 with an IC50 of 33 fiM. Compound2 was not tested in the AARAassay due to scarcity of material. correlated with the reactivity of (-f)-sclerotiorin with methylamine. Ochrephilone, however, did not react with methylamine. The most active compoundwith respect to reactivity with methylamine and induction of changes in fungal morphology was the azaphilone-related compoundcitrinin. Citrinin showed no activity in our rabbit ETAand rat ETBreceptor assays when tested at concentrations up to 300 /iM. The azaphilones discussed here thus appear to act as endothelin receptor antagonists by a mechanism not involving simple reactivity with amine functionalities. 921 The IC50 values of compounds 1, 2 and 3 (9, 28, 5/im) compare well with IC50 values for inhibition of ET-1 binding to the ETAreceptor reported for other fungal metabolites such as asterric acid (IO jUm) and aselacin A (22jUM)26 '27) .
In contrast compounds isolated from actinomycetes are reported to have somewhat more potent inhibitory properties as exemplified by cochinmycin A (0.24/jm) and the benzanthraquinone WS009A
(0.67/iM)24 '25) .
The IC50 values for asterric acid and BE-18257B in the rabbit ETA assay were in good agreement with those reported23'26*. Compounds 1, 2 and 3 were more selective for rabbit ETAreceptors whilst 5 and 6 are more selective for rat ETB receptors. In general all the compounds were less active when tested against the human receptors. A trend towards higher IC50 values was observed when the compoundswere tested in rabbit ETA and rat ETB receptor assays whenthe pre-incubation step was omitted (data not shown). Considerable experimental data reveals that endothelin stimulates phospholipase A2 to produce arachidonatederived secondary messengers such as prostaglandins, thromboxanes and leukotrienes2). Activity was observed for the most potent compounds in the AARAassay, demonstrating their ability to block ET-1 mediated arachidonic acid release in a complex physiologically relevant assay. 
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